PT - JOURNAL ARTICLE AU - Noah Reich AU - Christopher F. Lowe AU - David Puddicombe AU - Nancy Matic AU - Jesse Greiner AU - Janet Simons AU - Victor Leung AU - Terry Chu AU - Hiten Naik AU - Nick Myles AU - Laura Burns AU - Marc G. Romney AU - Gordon Ritchie AU - Sylvie Champagne AU - Kent Dooley AU - Inna Sekirov AU - Aleksandra Stefanovic TI - Diagnostic accuracy of RT-PCR for detection of SARS-CoV-2 compared to a “composite reference standard” in hospitalized patients AID - 10.1101/2021.02.18.21252016 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.18.21252016 4099 - http://medrxiv.org/content/early/2021/02/22/2021.02.18.21252016.short 4100 - http://medrxiv.org/content/early/2021/02/22/2021.02.18.21252016.full AB - Background COVID-19 caused by the novel coronavirus SARS-CoV-2 has caused the greatest public health emergency of our time. Accurate laboratory detection of the virus is critical in order to contain the spread. Although real-time polymerase chain reaction (PCR) has been the cornerstone of laboratory diagnosis, there have been conflicting reports on the diagnostic accuracy of this method.Methods A retrospective review was performed on all hospitalized patients tested for SARS-CoV-2 (at St. Pauls Hospital in Vancouver, BC) from March 13 – April 12, 2020. Diagnostic accuracy of initial PCR on nasopharyngeal (NP) swabs was determined against a composite reference standard which included a clinical assessment of the likelihood of COVID-19 by medical experts, initial and repeat PCR, and post-hoc serological testing.Results A total of 323 patients were included in the study, 33 (10.2%) tested positive and 290 (89.8%) tested negative by initial PCR. Patients testing positive were more likely to exhibit features of cough (66.7% vs 39.3%), shortness of breath (63.6% vs 35.9%), fever (72.7% vs 27.6%), radiographic findings (83.3% vs 39.6%) and severe outcomes including ICU admission (24.2% vs 9.7%) and mortality (21.2% vs 6.2%) compared to patients testing negative. Serology was performed on 90 patients and correlation between serology and PCR was 98.9%. There were 90 patients included in the composite reference standard. Compared to the composite reference standard, initial PCR had sensitivity of 94.7% (95% CI 74.0 to 99.9%), specificity of 100% (95% CI 94.9 to 100%), positive predictive value of 100% (95% CI 81.5 to 100%) and a negative predictive value of 98.6% (95% CI 92.5 to 100%).Discussion Our study showed high sensitivity of PCR on NP swab specimens when compared to composite reference standard in hospitalized patients. High correlation of PCR with serological testing further increased confidence in the diagnostic reliability of properly collected NP swabs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRoche has provided us with Roche Elecsys Anti-SARS-CoV-2 serology test kits. However, Roche had no involvement with protocol development or manuscript write up.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Research Ethics Board, University of British Columbia.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData was summarized in the Tables. Additional data needed can be made available upon request.